Latest News about GSK plc
Recent news which mentions GSK plc
From CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
February 27, 2024
From CNBC.com News
Cramer's Lightning Round: 'Hold off' on Kroger
February 05, 2024
From CNBC.com News
GSK posts blowout RSV vaccine sales, raises outlook as shots give big pharma a boost
January 31, 2024
From CNBC.com News
5 things to know before the stock market opens Monday
January 29, 2024
From CNBC.com News
Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
January 14, 2024
From CNBC.com News
RSV vaccine from GSK shows potential to protect adults 50 to 59
October 25, 2023
From CNBC.com News
Moderna combination Covid, flu vaccine moves to final stage trial after positive data
October 04, 2023
From CNBC.com News
Covid, RSV and flu vaccines are now available — here's how to decide whether to get them together
September 15, 2023
From CNBC.com News
Moderna says flu vaccine showed promising results in phase three trial, paving path to approval
September 13, 2023
From CNBC.com News
Covid vaccine rollout begins early in the UK with new variant under watch
September 11, 2023
From CNBC.com News
From CNBC.com News
From CNBC.com News
GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales
July 26, 2023
From CNBC.com News
From CNBC.com News
From CNBC.com News
Pfizer, GSK RSV shots for older adults may prevent thousands of hospitalizations, CDC analysis says
June 22, 2023
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
FDA approves Pfizer RSV vaccine for older adults
May 31, 2023
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
The EU outlined its plan to equalize drug access and lower prices. Pharma firms are not happy
April 27, 2023
From CNBC.com News
Stocks making the biggest moves midday: Southwest Airlines, Goldman Sachs, Bellus Health and more
April 18, 2023
From CNBC.com News
J&J backs out of RSV vaccine race with rivals Pfizer and GSK
March 29, 2023
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.